Reprint

Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders)

Edited by
May 2021
206 pages
  • ISBN978-3-0365-1283-9 (Hardback)
  • ISBN978-3-0365-1282-2 (PDF)

This book is a reprint of the Special Issue Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders) that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary
This book includes a compilation of papers published in 2020 and 2021 focused on dual disorders, which are found in significant and growing numbers in both substance addiction and mental health clinics. These contributions assume a broad perspective ranging from exposure to genetic and neurobiological elements to factors such as personality and quality of life. In all cases, these papers aimed to be transferred to and to benefit clinical practice.
Format
  • Hardback
License
© by the authors
Keywords
temperament; character; personality; substance use disorder; schizophrenia; dual schizophrenia; psychiatric symptoms; global functioning; dual disorders; addiction; sleep; risk factors; Substance-use disorder; substance-related disorders; alcohol use disorder; post-traumatic stress disorder; dual disorders; childhood trauma; psychiatric disorders; rehabilitation centers; impulsive behavior; addictive disorders; dual disorders; flaws; conceptual framework; concurrent disorder; co-occurring disorder; dual diagnosis; dual pathology; addiction comorbidity; comorbid substance abuse; comorbid illicit use; comorbid addiction; comorbid mental illness; coexisting mental illness; psychological trauma; posttraumatic stress disorder; substance use disorders; dual diagnosis; prevalence; primary major depression; alcohol use disorder; alcohol induced major depression; biomarkers; comorbidity; clinical characteristics; GWAS; dual disorders (DD); insomnia; sleep disorders (SD); benzodiazepine use disorder (BUD); health-related quality of life; substance use disorder; dual disorders; major depressive disorder; dual depression; relapses; dual diagnosis; polysubstance addictions; gene polymorphisms; primary/substance-induced depression; cocaine use disorder; tryptophan; serotonin; kynurenine; cannabis; comorbidity; cannabis use disorder; co-occurring disorder; n/a